., the world's largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, announced today that MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, has selected Lumenis' MOSES technology Holmium Laser platform as the winner of its "Best New Surgical Technology Solution" award in the fourth annual MedTech Breakthrough Awards program.Used for a variety of urological indications, including kidney stone and BPH treatments, MOSES is a patent-protected pulse delivery technology that remarkably improves energy transmission, resulting in more efficient and faster procedures. Through a proprietary combination of holmium laser systems and fibers, MOSES technology optimizes laser energy transmission to increase stone ablation volume while reducing dependency on the working distance between the fiber and stone. In BPH MOSES unique pulse modulation allows for shorter and more efficient procedures, resulting in greater case volume while releasing patients home the same day. MOSES, chosen by 85% of the US Honor Roll List hospitals as their Urology laser platform of choice, is the only new laser platform that was proven to improve procedural outcomes in a double-blind randomized clinical trial – showing 20% faster procedural time compared to the standard laser technology. The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year's program attracted more than 3,750 nominations from over 15 different countries throughout the world.